KTN1

Kinectin · Q86UP2 · KTN1 on Sugi Atlas →

0 patent compounds predicted against KTN1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to KTN1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
A Trial to Assess the Safety and Efficacy of KRN23 in Epidermal Nevus Syndrome (ENS) PHASE4COMPLETED
A Study of KRN23 in Pediatric Patients With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE3COMPLETED
AK112 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/ Metastatic Triple-negative Breast Cancer PHASE3RECRUITING
A Study of the Efficacy and Safety of MT1621 in Thymidine Kinase 2 (TK2) Deficiency (Treatment naïve) PHASE3WITHDRAWN
Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer PHASE1/PHASE2COMPLETED
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation PHASE1/PHASE2RECRUITING
A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer PHASE2NOT_YET_RECRUITING
A Study of AK138D1 in Advanced Malignant Tumors PHASE1RECRUITING
A Study of KRN23 in Subjects With X-linked Hypophosphatemic Rickets/Osteomalacia PHASE1COMPLETED
Study of KRN951 in Patients With Solid Tumors PHASE1COMPLETED
Study of ABT-751 in Patients With Refractory Hematologic Malignancies PHASE1COMPLETED
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy EARLY_PHASE1RECRUITING
Molecular Analysis of Patients With Neuromuscular Disease nanRECRUITING
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome nanRECRUITING
Transcranial Magnetic Stimulation (TMS) Studies of Dystonia nanCOMPLETED
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Muscle Tissue Bank for Muscular Dystrophy nanCOMPLETED
Long-read Genome Sequencing for the Molecular Diagnosis of Dystonia nanRECRUITING
Molecular and Genetic Studies of Congenital Myopathies nanRECRUITING
Integrated Model for Promoting Parenting and Early School Readiness in Pediatrics nanCOMPLETED
Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation nanCOMPLETED
Improvements in Aerobic Fitness With Exercise Training: the Role of Myokines nanCOMPLETED
Genetic Study of Patients With Primary Ciliary Dyskinesia nanCOMPLETED
Hereditary Spastic Paraplegia Genomic Sequencing Initiative (HSPseq) nanRECRUITING
The Prevalence of RYR1-related Disease nanNOT_YET_RECRUITING
Dystonia Genotype-Phenotype Correlation nanRECRUITING
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN
Gait in Rare Diseases nanCOMPLETED
Observational Study in Patients With Cyclin-dependent Kinase-like 5 Deficiency Disorder nanACTIVE_NOT_RECRUITING
Changes in Skin Innervation of Neurologically Asymptomatic Type 2 Diabetic Patients: the Correlation With the Diabetic Parameters and Neurotrophins. nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a KTN1 binder may also engage these)

ProteinNameSimilarity
Q61595 1.000 Q61595 →
O97961 1.000 O97961 →
Q90631 1.000 Q90631 →
Q8CHG3 0.994 Q8CHG3 →
Q8IWJ2 0.994 Q8IWJ2 →
Q7YS99 0.993 Q7YS99 →
Q13439 0.992 Q13439 →
D3ZZL9 0.991 D3ZZL9 →
P97779 0.991 P97779 →
UACA Uveal autoantigen with coiled-coil domains and ankyrin repeats 0.991 landscape →
Q8CDI7 0.991 Q8CDI7 →
P49454 0.991 P49454 →
Q5RCA7 0.990 Q5RCA7 →
Q7Z7B0 0.990 Q7Z7B0 →
Q9CW79 0.990 Q9CW79 →
A7MD70 0.990 A7MD70 →
Q8NCX0 0.990 Q8NCX0 →
Q6AY97 0.989 Q6AY97 →
Q9D8L5 0.989 Q9D8L5 →
Q0WVL7 0.989 Q0WVL7 →
Q14789 0.989 Q14789 →
Q7FAD5 0.989 Q7FAD5 →
EEA1 Early endosome antigen 1 0.988 landscape →
Q6TFL3 0.988 Q6TFL3 →
Q70FJ1 0.988 Q70FJ1 →
O42184 0.988 O42184 →
Q99996 0.988 Q99996 →
Q92805 0.987 Q92805 →
Q68D86 0.987 Q68D86 →
Q5U312 0.987 Q5U312 →